Matthew R. Reynolds, MD, MSc

Current Clinical Characteristics and Economic Impact of Subacute Stent Thrombosis

08/01/2008

Michael J. Rinaldi , MD, FACC, FSCAI;

Matthew R. Reynolds , MD, MSc;

Duane S. Pinto , MD, MPH;

David J. Cohen , MD, MPH, MSc;

Stent thrombosis represents an infrequent but potentially grave complication of percutaneous coronary intervention (PCI). With current antithrombotic regimens, stent thrombosis occurs after fewer than 1% of stent-based interventions,1,2 but...

Stent thrombosis represents an...

08/01/2008

Journal of Invasive Cardiology

Subacute Stent Thrombosis: Case Presentation and Brief Review

06/19/2008

Matthew R. Reynolds , MD, MSc;

Donald E. Cutlip , MD;

Case presentation. An 83 year-old woman with chronic exertional angina presented to an outside hospital with new rest symptoms and was diagnosed with a non-ST segment elevation myocardial infarction (MI). Five years earlier, coronary...

Case presentation. An 83...

06/19/2008

Cath Lab Digest

Feature

Subacute Stent Thrombosis: Case Presentation and Brief Review

06/19/2008

Matthew R. Reynolds , MD, MSc;

Donald E. Cutlip , MD;

Case presentation. An 83...

06/19/2008

Cath Lab Digest

Review

Advances in Atrial Fibrillation Ablation

05/04/2009

Joseph J. Germano , DO;

Alicia Darge ;

Matthew R. Reynolds , MD, MSc;

Atrial fibrillation (AF) is an increasingly common and costly medical problem.1–3 Given the disappointing efficacy and side effects associated with pharmacological therapy for AF, new treatment options are needed. Over the last decade,...

Atrial fibrillation (AF) is an...

05/04/2009

Journal of Invasive Cardiology